Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
E3 ubiquitin-protein ligase which promotes polyubiquitination and degradation by the proteasome pathway of ZIC2.. Zusätzlich bieten wir Ihnen RNF180 Antikörper (44) und viele weitere Produktgruppen zu diesem Protein an.
Showing 3 out of 6 products:
relationships between RNF180 promoter methylation and gastric cancer or atrophic gastritis, and the effects of Helicobactor pylori (H.pylori) infection on RNF180 promoter methylation
The methylated status of the key CpG islands of RNF180 DNA promoter may be used to predict the variations of the malignant biological characteristics of gastric cancer cells.
RNF180 is capable of inhibiting lymph node metastasis of gastric cancer by suppressing the intracellular activation of malignant molecular signals.
hypermethylated CpG site count of E3 ubiquitin ligase (zeige MUL1 Proteine) Ring finger protein 180 promoter for evaluating the prognosis of gastric cancer was reasonable by using the direct bisulfite sequencing.
We found that only few methylated CpG sites of RNF180 promoter was appropriate to predict the survival of gastric cancer
Data indicate that the ring finger protein 180 (RNF180) and HTR1A (zeige HTR1A Proteine) showed association to T1D in the Swedish and Danish families.
RNF180 is a novel potential tumor suppressor in gastric carcinogenesis.
Rines is a critical regulator of the monoaminergic system and emotional behavior and identify a promising candidate drug target for treating diseases associated with emotion.
The involvement of RNF180 in the ubiquitin-proteasome pathway was further supported by its binding to the UbcH6 (zeige UBE2E1 Proteine) ubiquitin-conjugating enzyme (zeige Ube2t Proteine) and by its trans-ubiquitination enhancing activities.
E3 ubiquitin-protein ligase which promotes polyubiquitination and degradation by the proteasome pathway of ZIC2.
E3 ubiquitin-protein ligase RNF180